Outcome, Fatal
37
2
2
23
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 37 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (37)
Resistant Bacteria in Children in France
Russian Registry of Surgical OutcomeS
Apatinib for Resectable Colorectal Cancer
Protocol for Patients Above 75 Years Undergoing Emergency Laparotomy
Invasive Group A Streptococcal Infection
Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab Application
International Study of Inflammation in COVID-19
Early Warning of Delayed Cerebral Ischemia
Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.
Neutral Versus Liberal fLuId In Traumatic Brain Injury: a Randomised Controlled Trial
Outcome After Out of Hospital Cardiac Arrest in Bern, Switzerland
Spine Registry University Hospital of Cologne- Department of Orthopedics
The HIV Testing Trends and Outcomes at a Johannesburg Trauma ICU Unit
Preoperative Care In Ovarian Cancer Patients
Decrease Artery Occlusion by Distal Radial Arterial Cannulation, Observational Study
Oxygen Pulse and Its Curve Patterns in Male Patients With Heart Failure and Chronic Obstructive Pulmonary Disease With and in Healthy Men
Patterns and Outcomes of Neurosurgery in England Over a Five-year Period
Outcomes of Transposition of the Great Arteries After Arterial Switch Operation
Analysis of Mortality of Critically Ill Patients With COVID-19
Artificial Intelligence Prediction for the Severity of Acute Pancreatitis